Literature DB >> 35013901

Together-Equitable-Accessible-Meaningful (TEAM) Training to Improve Cancer Care for Sexual and Gender Minorities (SGM): Outcomes from a Pilot Study.

Mandi L Pratt-Chapman1,2, Yan Wang3, Kristen Eckstrand4, Asa Radix5, Gwendolyn P Quinn6, Matthew B Schabath7, Ana Maria Lopez8.   

Abstract

To alleviate health disparities experienced by sexual and gender minority (SGM) patients, cancer care professionals need further education on the needs of SGM cancer patients and their loved ones and caregivers. The Together-Equitable-Accessible-Meaningful (TEAM) Training to Improve Cancer Care for SGM Patients (TEAM SGM) was developed and piloted to address this need. This study reports healthcare professional learner outcomes from the TEAM SGM pilot intervention. The TEAM SGM Training pilot consisted of 2.5 h of content from the original online self-paced TEAM Training plus 12 1-h Zoom sessions on specialized topics in addition to readings and activities. Participants (n = 28), representing seven cancer service organizations from six states in the USA, were recruited through newsletter listservs and social media. All participants (n = 28) completed the pre-test and twenty-two participants completed the post-test. Using five factors confirmed in a separate Confirmatory Factor Analysis, paired t-tests of TEAM SGM participant pre- and post-test data were conducted. Statistically significant improvements were found in four of five factors: Environmental Cues (t(21) = 2.56, p = .018), Knowledge (t(21) = 2.15, p = .043), Clinical Preparedness (t(7) = 3.89, p = .006), Clinical Behaviors (t(21) = 2.48, p = .022). The Attitudes factor was not significantly improved from pre-intervention to post-intervention likely due to strong affirming attitudes toward SGM patients at baseline. TEAM SGM is a feasible, effective training to build capacity in SGM-affirming care for cancer care providers.
© 2022. The Author(s) under exclusive licence to American Association for Cancer Education.

Entities:  

Keywords:  Cultural competency training; Healthcare professional education; LGBTQI

Year:  2022        PMID: 35013901      PMCID: PMC9271127          DOI: 10.1007/s13187-022-02134-2

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   1.771


  4 in total

1.  American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority Populations.

Authors:  Jennifer Griggs; Shail Maingi; Victoria Blinder; Neelima Denduluri; Alok A Khorana; Larry Norton; Michael Francisco; Dana S Wollins; Julia H Rowland
Journal:  J Clin Oncol       Date:  2017-04-03       Impact factor: 44.544

2.  National Survey of Oncologists at National Cancer Institute-Designated Comprehensive Cancer Centers: Attitudes, Knowledge, and Practice Behaviors About LGBTQ Patients With Cancer.

Authors:  Matthew B Schabath; Catherine A Blackburn; Megan E Sutter; Peter A Kanetsky; Susan T Vadaparampil; Vani N Simmons; Julian A Sanchez; Steven K Sutton; Gwendolyn P Quinn
Journal:  J Clin Oncol       Date:  2019-01-16       Impact factor: 44.544

3.  Stigma as a fundamental cause of population health inequalities.

Authors:  Mark L Hatzenbuehler; Jo C Phelan; Bruce G Link
Journal:  Am J Public Health       Date:  2013-03-14       Impact factor: 9.308

4.  Learning Outcomes of Diverse Oncology Professionals After the TEAM Cultural Competency Training.

Authors:  Mandi L Pratt-Chapman
Journal:  J Cancer Educ       Date:  2020-09-09       Impact factor: 1.771

  4 in total
  1 in total

1.  Developing Standards for Cultural Competency Training for Health Care Providers to Care for Lesbian, Gay, Bisexual, Transgender, Queer, Intersex, and Asexual Persons: Consensus Recommendations from a National Panel.

Authors:  Mandi L Pratt-Chapman; Kristen Eckstrand; Amorie Robinson; Lauren B Beach; Charles Kamen; Alex S Keuroghlian; Scott Cook; Asa Radix; Markus P Bidell; Daniel Bruner; Liz Margolies
Journal:  LGBT Health       Date:  2022-04-19       Impact factor: 5.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.